Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for To Consider And Approve The Audited Financial Results (Standalone And Consolidated) Of The Company Under Ind AS For The Fourth Quarter And Year Ended 31St March, 2021 And Related Matters

SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2021 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Tuesday, the 04th May, 2021 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, inter alia, and take on record the following matter(s): To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the fourth quarter and year ended 31st March, 2021 and related matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st April, 2021 as per PIT Code of the Company. Trading window will be opened from 7th May, 2021. You are requested to take this notice on your record.
27-04-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Non-Applicability Of SESI Circular - SESI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018 Issued In Respect Of "Large Corporate"

With reference to the subject, we hereby confirm that for the financial year ended 31st March, 2021 our Company is not falling under the category of "Large Corporate" as per the applicability criteria mentioned in SEBI Circular - SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. Please take this information on your record.
23-04-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 012120 Name of the Signatory :- Shrenik SoniDesignation :- Company Secretary and Compliance Officer
17-04-2021
Bigul

Suven Life Sciences Ltd - 530239 - Submission Of Compliance Certificate Under Regulation 40(10) For The Half-Year Ended 31St March, 2021.

With reference to above subject, please find enclosed Compliance Certificate for the half-year ended 31st March, 2021 issued by the Practicing Company Secretary, under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We request you to take this document on your record.
16-04-2021
Bigul

Suven Life Sciences Ltd - 530239 - Shareholding for the Period Ended March 31, 2021

Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
14-04-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended 31St March, 2021

With reference to the above subject, please find enclosed Compliance Certificate for the half-year ended 31st March, 2021 duly signed by the Compliance Officer and authorized representative of the Share Transfer Agent i.e. (KFIN Technologies Private Limited, Hyderabad), under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We request you to take this document on your record.
08-04-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended March 31, 2021, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by KFin Technologies Private Limited, Registrar & Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Private Limited dated April 03, 2021 are enclosed for your reference. This is for your information and record.
08-04-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Allotment

With reference to the subject matter, we wish to inform you that in terms of the special resolution passed by the Members of the Company at its Extra-Ordinary General Meeting held on 20th March, 2021 and in accordance with the 'In-principle approval' granted by the NSE and BSE, the Board of Directors of the Company in its meeting held today i.e. 02nd April, 2021 has allotted 1,81,00,000 (One crore eighty one lakh) Warrants convertible into Equity Shares to Jasti Property and Equity Holdings Private Limited (In its capacity as sole trustee of Jasti Family Trust), promoter group entity at an issue price of Rs. 81.57/- per Warrant on preferential basis in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
02-04-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window

We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st April, 2021 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter and year ending 31st March, 2021, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This is for your information and record.
31-03-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
22-03-2021
Next Page
Close

Let's Open Free Demat Account